FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jos van Strijp

Research Profile

Anatomy

Living Beings

Physiology

Phagocytosis

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
Ilse Jongerius; Jörg Köhl; Manoj Pandey; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp; Suzan H M Rooijakkers
Staphylococcal complement evasion by various convertase-blocking molecules.
Suzan H M Rooijakkers; Fin J Milder; Bart W Bardoel; Maartje Ruyken; Jos van Strijp; Piet Gros
Staphylococcal complement inhibitor: structure and active sites.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jos van Strijp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Alexander Laarman; Fin Milder; Jos van Strijp; Suzan Rooijakkers
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
Journal of molecular medicine (Berlin, Germany) 2010;88(2):115-20.
2007: Ilse Jongerius; Jörg Köhl; Manoj Pandey; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp; Suzan H M Rooijakkers
Staphylococcal complement evasion by various convertase-blocking molecules.
The Journal of experimental medicine 2007;204(10):2461-71.
2007: Suzan H M Rooijakkers; Fin J Milder; Bart W Bardoel; Maartje Ruyken; Jos van Strijp; Piet Gros
Staphylococcal complement inhibitor: structure and active sites.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(5):2989-98.
2007: Jovanka Bestebroer; Miriam J J G Poppelier; Laurien H Ulfman; Peter J Lenting; Cécile V Denis; Kok P M van Kessel; Jos van Strijp; Carla J C de Haas
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
Blood 2007;109(7):2936-43.
2007: Pieter-Jan Haas; Jos van Strijp
Anaphylatoxins: their role in bacterial infection and inflammation.
Immunologic research 2007;37(3):161-75.
2007: Suzan H M Rooijakkers; Jos van Strijp
Bacterial complement evasion.
Molecular immunology 2007;44(1-3):23-32.
2006: Cristina Prat; Jovanka Bestebroer; Carla J C de Haas; Jos van Strijp; Kok P M van Kessel
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(11):8017-26.
2006: Suzan H M Rooijakkers; Maartje Ruyken; Jos van Roon; Kok P M van Kessel; Jos van Strijp; Willem J B Van Wamel
Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus.
Cellular microbiology 2006;8(8):1282-93.
2006: Frank E J Coenjaerts; Andy I M Hoepelman; Jelle Scharringa; Marieke Aarts; Pauline M Ellerbroek; Lisette Bevaart; Jos van Strijp; Guilhem Janbon
The Skn7 response regulator of Cryptococcus neoformans is involved in oxidative stress signalling and augments intracellular survival in endothelium.
FEMS yeast research 2006;6(4):652-61.
2006: Judy Higgins; Anthony Loughman; Kok P M van Kessel; Jos van Strijp; Timothy J Foster
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
FEMS microbiology letters 2006;258(2):290-6.
2006: Willem J B Van Wamel; Suzan H M Rooijakkers; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp
The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.
Journal of bacteriology 2006;188(4):1310-5.
2006: Manuela Dürr; Sascha Kristian; Michael Otto; Gianluca Matteoli; Peter S Margolis; Joaquim Trias; Kok P M van Kessel; Jos van Strijp; Erwin Bohn; Regine Landmann; Andreas Peschel
Neutrophil chemotaxis by pathogen-associated molecular patterns--formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus.
Cellular microbiology 2006;8(2):207-17.
2005: Suzan H M Rooijakkers; Kok P M van Kessel; Jos van Strijp
Staphylococcal innate immune evasion.
Trends in microbiology 2005;13(12):596-601.
2005: Pieter-Jan Haas; Carla J C de Haas; Miriam J J G Poppelier; Kok P M van Kessel; Jos van Strijp; Klaas Dijkstra; Ruud M Scheek; Hao Fan; John A W Kruijtzer; Rob M J Liskamp; Johan Kemmink
The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules.
Journal of molecular biology 2005;353(4):859-72.
2005: Suzan H M Rooijakkers; Maartje Ruyken; Anja Roos; Mohamed R Daha; Julia S Presanis; Robert B Sim; Willem J B Van Wamel; Kok P M van Kessel; Jos van Strijp
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
Nature immunology 2005;6(9):920-7.
2005: Henk J van Leeuwen; M Van Der Tol; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
The role of tumour necrosis factor in the kinetics of lipopolysaccharide-mediated neutrophil priming in whole blood.
Clinical and experimental immunology 2005;140(1):65-72.
2005: Suzan H M Rooijakkers; Willem J B Van Wamel; Maartje Ruyken; Kok P M van Kessel; Jos van Strijp
Anti-opsonic properties of staphylokinase.
Microbes and infection / Institut Pasteur 2005;7(3):476-84.
2005: Bent Postma; Wendy Kleibeuker; Miriam J J G Poppelier; Miranda Boonstra; Kok P M van Kessel; Jos van Strijp; Carla J C de Haas
Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.
The Journal of biological chemistry 2005;280(3):2020-7.
2005: Lizette Visser; Hendrik Jan de Heer; Leonie A Boven; Debby van Riel; Marjan van Meurs; Marie-José Melief; Ulrich Zähringer; Jos van Strijp; Bart N Lambrecht; Edward E S Nieuwenhuis; Jon D Laman
Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):808-16.
2004: Pieter-Jan Haas; Carla J C de Haas; Wendy Kleibeuker; Miriam J J G Poppelier; Kok P M van Kessel; John A W Kruijtzer; Rob M J Liskamp; Jos van Strijp
N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(9):5704-11.
2004: Bent Postma; Miriam J J G Poppelier; Joost van Galen; Eric R Prossnitz; Jos van Strijp; Carla J C de Haas; Kok P M van Kessel
Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):6994-7001.
2004: Péter Antal-Szalmás; Miriam J J G Poppelier; Andrea Sümegi; Tjomme van der Bruggen; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.
Immunology letters 2004;93(1):11-5.
2004: Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M van Kessel; Jos van Strijp
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
The Journal of experimental medicine 2004;199(5):687-95.
2003: Henk J van Leeuwen; Eric C J M Heezius; Geesje M Dallinga; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
Lipoprotein metabolism in patients with severe sepsis.
Critical care medicine 2003;31(5):1359-66.
2003: Nina M van Sorge; Leonard H Van den Berg; Karin Geleijns; Jos van Strijp; Bart C Jacobs; Pieter A Van Doorn; J H J Wokke; Jan G J van de Winkel; Jeanette Leusen; W-Ludo van der Pol
Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
Annals of neurology 2003;53(5):570-9.
2003: Sonja Von Aulock; Siegfried Morath; Lars Hareng; Sylvia Knapp; Kok P M van Kessel; Jos van Strijp; Thomas Hartung
Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment.
Immunobiology 2003;208(4):413-22.
2003: Kok P M van Kessel; Karin Ellen Veldkamp; Andreas Pesschel; Carla J C de Haas; Jan Verhoef; Jos van Strijp
Tips and tricks from Staphylococcus aureus.
Advances in experimental medicine and biology 2003;531():341-9.
2003: Sascha Kristian; Manuela Dürr; Jos van Strijp; Birgid Neumeister; Andreas Peschel
MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing.
Infection and immunity 2003;71(1):546-9.
2002: L Vincent Collins; Sascha Kristian; Christopher Weidenmaier; Marion Faigle; Kok P M van Kessel; Jos van Strijp; Friedrich Götz; Birgid Neumeister; Andreas Peschel
Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.
The Journal of infectious diseases 2002;186(2):214-9.
2001: Philipp Henneke; Osamu Takeuchi; Jos van Strijp; Hilde-Kari Guttormsen; J A Smith; Andra B Schromm; Terje Espevik; Shizuo Akira; V Nizet; Dennis L Kasper; Douglas T Golenbock
Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(12):7069-76.
2001: J Koenraad van de Wetering; Martin van Eijk; Lambert M G van Golde; Thomas Hartung; Jos van Strijp; Joseph J Batenburg
Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria.
The Journal of infectious diseases 2001;184(9):1143-51.
2001: Péter Antal-Szalmás; I Szöllosi; Gabriella Lakos; Emese Kiss; István Csípo; Andrea Sümegi; Sándor Sipka; Jos van Strijp; Kok P M van Kessel; Gyula Szegedi
A novel flow cytometric assay to quantify soluble CD14 concentration in human serum.
Cytometry 2001;45(2):115-23.
2001: Frank E J Coenjaerts; Annemiek M E Walenkamp; Pauline N M Mwinzi; Jelle Scharringa; H A Dekker; Jos van Strijp; R Cherniak; Andy I M Hoepelman
Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(7):3988-95.
2001: Henk J van Leeuwen; André P Van Beek; Geesje M Dallinga-Thie; Jos van Strijp; Jan Verhoef; Kok P M van Kessel
The role of high density lipoprotein in sepsis.
The Netherlands journal of medicine 2001;59(3):102-10.
2001: Andreas Peschel; Ralph W Jack; Michael Otto; L Vincent Collins; Petra Staubitz; G Nicholson; Hubert Kalbacher; Willem F Nieuwenhuizen; Günther Jung; A Tarkowski; Kok P M van Kessel; Jos van Strijp
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.
The Journal of experimental medicine 2001;193(9):1067-76.
2000: Péter Antal-Szalmás; Miriam J J G Poppelier; Roel Broekhuizen; Jan Verhoef; Jos van Strijp; Kok P M van Kessel
Diverging pathways for lipopolysaccharide and CD14 in human monocytes.
Cytometry 2000;41(4):279-88.
2000: Karin Ellen Veldkamp; H C Heezius; Jan Verhoef; Jos van Strijp; Kok P M van Kessel
Modulation of neutrophil chemokine receptors by Staphylococcus aureus supernate.
Infection and immunity 2000;68(10):5908-13.
2000: Carla J C de Haas; Miriam J J G Poppelier; Kok P M van Kessel; Jos van Strijp
Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.
Infection and immunity 2000;68(9):4954-60.
2000: Carla J C de Haas; Henk J van Leeuwen; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.
Journal of immunological methods 2000;242(1-2):79-89.
2000: Edwin Boel; S Verlaan; Miriam J J G Poppelier; N A Westerdaal; Jos van Strijp; Ton Logtenberg
Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments.
Journal of immunological methods 2000;239(1-2):153-66.
2000: Carla J C de Haas; E M van Leeuwen; Toon van Bommel; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.
Infection and immunity 2000;68(4):1753-9.
1999: Carla J C de Haas; R van der Zee; Barry Benaissa-Trouw; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS.
Infection and immunity 1999;67(6):2790-6.
1999: Annet Troelstra; LA de Graaf-Miltenburg; Toon van Bommel; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(7):4220-5.
1999: Annemiek van Spriel; IE van den Herik-Oudijk; Nina M van Sorge; Henriëtte Vilé; Jos van Strijp; Jan G J van de Winkel
Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils.
The Journal of infectious diseases 1999;179(3):661-9.
1998: Carla J C de Haas; Pieter-Jan Haas; Kok P M van Kessel; Jos van Strijp
Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology.
Biochemical and biophysical research communications 1998;252(2):492-6.
1998: Carla J C de Haas; M E van der Tol; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3607-15.
1997: Franz-Josef Schmitz; Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst.
The Journal of infectious diseases 1997;176(6):1531-7.
1997: Karin Ellen Veldkamp; Kok P M van Kessel; Jan Verhoef; Jos van Strijp
Staphylococcal culture supernates stimulate human phagocytes.
Inflammation 1997;21(5):541-51.
1997: Johannes G Kusters; M M Gerrits; Jos van Strijp; Christina M.J.E, Vandenbroucke-Grauls
Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death.
Infection and immunity 1997;65(9):3672-9.
1997: Annet Troelstra; P Antal-Szalmas; LA de Graaf-Miltenburg; Annemarie J L Weersink; Jan Verhoef; Kok P M van Kessel; Jos van Strijp
Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
Infection and immunity 1997;65(6):2272-7.
1997: CA Benne; Barry Benaissa-Trouw; Jos van Strijp; CA Kraaijeveld; J F van Iwaarden
Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages.
European journal of immunology 1997;27(4):886-90.
1997: Annet Troelstra; B N Giepmans; Kok P M van Kessel; H S Lichenstein; Jan Verhoef; Jos van Strijp
Dual effects of soluble CD14 on LPS priming of neutrophils.
Journal of leukocyte biology 1997;61(2):173-8.
1995: J C Pikaar; WF Voorhout; Lambert M G van Golde; Jan Verhoef; Jos van Strijp; J F van Iwaarden
Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.
The Journal of infectious diseases 1995;172(2):481-9.
1995: C A Benne; CA Kraaijeveld; Jos van Strijp; E Brouwer; M Harmsen; Jan Verhoef; Lambert M G van Golde; J F van Iwaarden
Interactions of surfactant protein A with influenza A viruses: binding and neutralization.
The Journal of infectious diseases 1995;171(2):335-41.
1994: E S Van Amersfoort; Jos van Strijp
Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes.
Cytometry 1994;17(4):294-301.
1994: E A DeVelasco; H A Dekker; P Antal; K P Jalink; Jos van Strijp; AF Verheul; Jan Verhoef; Harm Snippe
Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.
Vaccine 1994;12(15):1419-22.
1994: J F Van Iwaarden; J C Pikaar; J Storm; E Brouwer; Jan Verhoef; R S Oosting; Lambert M G van Golde; Jos van Strijp
Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides.
The Biochemical journal 1994;303 ( Pt 2)():407-11.
1994: L A De Graaf-Miltenburg; K E Van Vliet; T L Ten Hagen; Jan Verhoef; Jos van Strijp
The role of HSV-induced Fc- and C3b (i)-receptors in bacterial adherence.
Journal of medical microbiology 1994;40(1):48-54.
1993: C P Timmerman; E Mattsson; L Martinez-Martinez; Loek de Graaf; Jos van Strijp; Henri A Verbrugh; Jan Verhoef; André Fleer
Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans.
Infection and immunity 1993;61(10):4167-72.
1993: Jos van Strijp; D G Russell; Elaine I Tuomanen; E J Brown; Samuel D Wright
Ligand specificity of purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect effects of an Arg-Gly-Asp (RGD) sequence.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):3324-36.
1993: Hans S L M Nottet; Loek de Graaf; NM de Vos; L J Bakker; Jos van Strijp; Maarten R Visser; Jan Verhoef
Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1993;168(1):84-91.
1993: Hans S L M Nottet; Loek de Graaf; N Machiel de Vos; L J Bakker; Jos van Strijp; Maarten R Visser; Jan Verhoef
Down-regulation of human immunodeficiency virus type (HIV-1) production after stimulation of monocyte-derived macrophages infected with HIV-1.
The Journal of infectious diseases 1993;167(4):810-7.
1993: P Joling; L J Bakker; Jos van Strijp; T Meerloo; Loek de Graaf; M E Dekker; J Goudsmit; Jan Verhoef; Henk-Jan Schuurman
Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):1065-73.
1993: K E Van Vliet; L A De Graaf-Miltenburg; Jan Verhoef; Jos van Strijp
A flow cytometric rosetting assay for the analysis of Fc receptors and C3 receptors on HSV-infected cells.
Journal of immunological methods 1993;157(1-2):57-64.
1993: P Joling; L J Bakker; Dick F van Wichen; Loek de Graaf; T Meerloo; Maarten R Visser; Jos van Strijp; J Goudsmit; Jan Verhoef; Henk-Jan Schuurman
Binding of HIV-1 to human follicular dendritic cells.
Advances in experimental medicine and biology 1993;329():455-60.
1993: Annemarie J L Weersink; Kok P M van Kessel; M E van den Tol; Jos van Strijp; Ruurd Torensma; Jan Verhoef; P Elsbach; J Weiss
Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(1):253-63.
1992: J F van Iwaarden; Jos van Strijp; H Visser; Henk P Haagsman; Jan Verhoef; Lambert M G van Golde
Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.
The Journal of biological chemistry 1992;267(35):25039-43.
1992: K E Van Vliet; L A De Graaf-Miltenburg; Jan Verhoef; Jos van Strijp
Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.
Immunology 1992;77(1):109-15.
1992: A Hermanowski-Vosatka; Jos van Strijp; W J Swiggard; Samuel D Wright
Integrin modulating factor-1: a lipid that alters the function of leukocyte integrins.
Cell 1992;68(2):341-52.
1992: L J Bakker; Hans S L M Nottet; NM de Vos; Loek de Graaf; Jos van Strijp; Maarten R Visser; Jan Verhoef
Antibodies and complement enhance binding and uptake of HIV-1 by human monocytes.
AIDS (London, England) 1992;6(1):35-41.
1991: Kok P M van Kessel; Jos van Strijp; Jan Verhoef
Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(11):3862-8.
1991: J F van Iwaarden; Jos van Strijp; M J Ebskamp; A C Welmers; Jan Verhoef; Lambert M G van Golde
Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages.
The American journal of physiology 1991;261(2 Pt 1):L204-9.
1991: Jos van Strijp; M E van der Tol; L A Miltenburg; Kok P M van Kessel; Jan Verhoef
Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.
Immunology 1991;73(1):77-82.
1990: Kok P M van Kessel; Jos van Strijp; H J van Kats-Renaud; L A Miltenburg; Ad C Fluit; Jan Verhoef
Uncoupling of oxidative and non-oxidative mechanisms in human granulocyte-mediated cytotoxicity: use of cytoplasts and cells from chronic granulomatous disease patient.
Journal of leukocyte biology 1990;48(4):359-66.
1990: Annemarie J L Weersink; Kok P M van Kessel; Ruurd Torensma; Jos van Strijp; Jan Verhoef
Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(1):318-24.
1990: Jos van Strijp; L A Miltenburg; M E van der Tol; Kok P M van Kessel; Ad C Fluit; Jan Verhoef
Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes.
The Journal of general virology 1990;71 ( Pt 5)():1205-9.
1989: Ad C Fluit; Jos van Strijp; L A Miltenburg; C P van Kessel; H Snippe; Jan Verhoef
The use of a hybridization assay for the study of host defences against herpes simplex virus.
Journal of virological methods 1989;26(3):269-78.
1989: Kok P M van Kessel; Jos van Strijp; M E van der Tol; H J van Kats-Renaud; R M Thijssen; Ad C Fluit; Jan Verhoef
Quantitation of conjugate formation between human polymorphonuclear leukocytes and antibody-coated target cells by flow cytometry: the role of Fc receptor and LFA-1 antigen.
Journal of leukocyte biology 1989;46(5):467-75.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Jan Verhoef
Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.
The Journal of clinical investigation 1989;84(1):107-12.
1989: Kok P M van Kessel; Jos van Strijp; L M Miltenburg; H J Van Kats-Renaud; Ad C Fluit; Jan Verhoef
Antibody-coated target cell membrane-induced chemiluminescence by human polymorphonuclear leukocytes.
Journal of immunological methods 1989;118(2):279-85.
1989: Jos van Strijp; Kok P M van Kessel; M E van der Tol; Ad C Fluit; Harm Snippe; Jan Verhoef
Phagocytosis of herpes simplex virus by human granulocytes and monocytes.
Archives of virology 1989;104(3-4):287-98.
1988: Jos van Strijp; Kok P M van Kessel; L A Miltenburg; Ad C Fluit; Jan Verhoef
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.
Journal of virology 1988;62(3):847-50.
1987: Kok P M van Kessel; Jos van Strijp; H J Van Kats-Renaud; L A Miltenburg; M E Van Der Tol; Ad C Fluit; Jan Verhoef
Further evidence against a role for toxic oxygen products as lytic agents in NK cell-mediated cytotoxicity.
Immunology 1987;62(4):675-8.
1986: Kok P M van Kessel; Maarten R Visser; Jos van Strijp; J H van Kats-Renaud; J Verhoef
Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.
Immunology 1986;58(2):291-6.
1986: Kok P M van Kessel; H J Van Kats-Renaud; Jos van Strijp; Maarten R Visser; Jan Verhoef
Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.
Journal of immunological methods 1986;88(1):101-7.
1985: M Rozenberg-Arska; M E Salters; Jos van Strijp; J J Geuze; Jan Verhoef
Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes.
Infection and immunity 1985;50(3):852-9.
1984: M Rozenberg-Arska; Jos van Strijp; W P Hoekstra; Jan Verhoef
Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase.
The Journal of clinical investigation 1984;73(5):1254-62.
1984: M Rozenberg-Arska; E C Salters; Jos van Strijp; W P Hoekstra; Jan Verhoef
Degradation of Escherichia coli chromosomal and plasmid DNA in serum.
Journal of general microbiology 1984;130(1):217-22.